J&J's DePuy gains rights to MinMaxMedical Gemtrack tech
Source: SeekingAlpha
2026-05-26 12:46:42 ET
More on Johnson & Johnson
- Johnson & Johnson: A Dividend King, But Priced Appropriately, Big Conference Slate
- FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
- Johnson & Johnson (JNJ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
- Notable analyst calls this week: Dell, J&J and AMD stocks among top picks
- FDA leadership fallout continues as acting CDER Director Hoeg departs
Read the full article on Seeking Alpha
For further details see:
J&J's DePuy gains rights to MinMaxMedical Gemtrack tech
Johnson & Johnson
NASDAQ: JNJ
JNJ Trading
1.11% G/L:
$226.56 Last:
719,760 Volume:
$227.09 Open:
JNJ Latest News
JNJ Stock Data
$577,845,337,264
2,385,202,151
0.01%
2802
N/A
Pharmaceuticals
Healthcare
US
New Brunswick
